Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""metformin - therapeutic use"" wg kryterium: Temat


Tytuł :
Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome
Autorzy :
Altinok, Magda Lambaa
Ravn, Pernille
Andersen, Marianne
Glintborg, Dorte
Pokaż więcej
Temat :
Adolescent
Adult
Contraceptives, Oral, Hormonal/therapeutic use
Female
Humans
Hypoglycemic Agents/therapeutic use
Metformin/therapeutic use
Polycystic Ovary Syndrome/drug therapy
Quality of Life
Treatment Outcome
Young Adult
Źródło :
Altinok, M L, Ravn, P, Andersen, M & Glintborg, D 2018, ' Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome ', Gynecological Endocrinology, vol. 34, no. 10, pp. 859-863 . https://doi.org/10.1080/09513590.2018.1460343
Tytuł :
No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients
Autorzy :
Steffensen, Lasse Bach
Feddersen, Søren
Preil, Simone Rørdam
Rasmussen, Lars Melholt
Pokaż więcej
Temat :
RC666-701
Mammary Arteries/drug effects
Diseases of the circulatory (Cardiovascular) system
Metformin/therapeutic use
Aged
MicroRNAs/genetics
Hypoglycemic Agents/therapeutic use
Diabetes Mellitus, Type 2/diagnosis
Artery
Middle Aged
Gene Expression Profiling/methods
endocrine system diseases
nutritional and metabolic diseases
Gene Expression Regulation
Microarray
Original Investigation
Oligonucleotide Array Sequence Analysis
MicroRNA
Female
Diabetes
Humans
Male
Case-Control Studies
Źródło :
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-10 (2018)
Steffensen, L B, Feddersen, S, Preil, S R & Rasmussen, L M 2018, ' No detectable differential microRNA expression between non-atherosclerotic arteries of type 2 diabetic patients (treated or untreated with metformin) and non-diabetic patients ', Cardiovascular Diabetology, vol. 17, 72 . https://doi.org/10.1186/s12933-018-0715-y
Cardiovascular Diabetology
Opis pliku :
application/pdf
Tytuł :
Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin:A MetGen Meta-Analysis
Autorzy :
Dujic, Tanja
Zhou, Kaixin
Yee, Sook Wah
van Leeuwen, Nienke
de Keyser, Catherine E
Javorský, Martin
Goswami, Srijib
Zaharenko, Linda
Christensen, Mette Marie H
Out, Mattijs
Tavendale, Roger
Kubo, Michiaki
Hedderson, Monique M
van der Heijden, Amber A
Klimčáková, Lucia
Pirags, Valdis
Kooy, Adriaan
Brøsen, Kim
Klovins, Janis
Semiz, Sabina
Tkáč, Ivan
Stricker, Bruno H
Palmer, Colin N A
't Hart, Leen M
Giacomini, Kathleen M
Pearson, Ewan R
Pokaż więcej
Temat :
Membrane Transport Proteins/genetics
endocrine system diseases
nutritional and metabolic diseases
Organic Cation Transporter 2
Databases, Factual
Octamer Transcription Factor-1/genetics
Polymorphism, Single Nucleotide
Diabetes Mellitus, Type 2/blood
Female
digestive, oral, and skin physiology
Phenotype
Pharmacogenomic Variants
Aged
Metformin/therapeutic use
Hypoglycemic Agents/therapeutic use
Glycated Hemoglobin A/metabolism
Blood Glucose/drug effects
Middle Aged
Treatment Outcome
Genotype
Organic Cation Transport Proteins/genetics
Aged, 80 and over
Biomarkers/blood
Humans
Male
Źródło :
Dujic, T, Zhou, K, Yee, S W, van Leeuwen, N, de Keyser, C E, Javorský, M, Goswami, S, Zaharenko, L, Christensen, M M H, Out, M, Tavendale, R, Kubo, M, Hedderson, M M, van der Heijden, A A, Klimčáková, L, Pirags, V, Kooy, A, Brøsen, K, Klovins, J, Semiz, S, Tkáč, I, Stricker, B H, Palmer, C N A, 't Hart, L M, Giacomini, K M & Pearson, E R 2017, ' Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin : A MetGen Meta-Analysis ', Clinical Pharmacology & Therapeutics, vol. 101, no. 6, pp. 763-772 . https://doi.org/10.1002/cpt.567
Opis pliku :
application/pdf
Tytuł :
Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization
Autorzy :
Ortega, Francisco J.
Mercader, Josep M.
Moreno-Navarrete, José Maria
Rovira, Oscar
Guerra, Ester
Esteve, Eduardo
Xifra, Gemma
Martinez, Cristina
Ricart, Wifredo
Rieusset, Jennifer
Rome, Sophie
Karczewska-Kupczewska, Monika
Straczkowski, Marek
Fernández-Real, José Manuel
Pokaż więcej
Temat :
pharmacology"*"Insulin Resistance
genetics"*"Double-Blind Method"*"Female"*"Humans"*"Hypoglycemic Agents
drug therapy
Type 2
pharmacology"*"Insulin
blood
endocrine system diseases
Adolescent"*"Adult"*"Aged"*"Biological Markers/metabolism"*"Cross-Sectional Studies"*"Diabetes Mellitus
genetics"*"Male"*"Metformin
metabolism"*"Middle Aged"*"Pilot Projects"*"Young Adult
administration & dosage
Type 2/blood/drug therapy/*genetics"*"Double-Blind Method"*"Female"*"Humans"*"Hypoglycemic Agents/administration & dosage/pharmacology"*"Insulin/administration & dosage/pharmacology"*"Insulin Resistance/*genetics"*"Male"*"Metformin/therapeutic use"*"MicroRNAs/*metabolism"*"Middle Aged"*"Pilot Projects"*"Young Adult
[SDV]Life Sciences [q-bio]
therapeutic use"*"MicroRNAs
Źródło :
Diabetes Care, American Diabetes Association, 2014, 37 (5), pp.1375-1383. ⟨10.2337/dc13-1847⟩

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies